GLP-1 Receptor Agonists Tied to Risks and Benefits Beyond Weight Loss
Reduced risks seen for neurocognitive, coagulation, cardiometabolic disorders; increased risks seen for GI, arthritic disorders
New Criteria Developed for Appropriate Use of Amyloid, Tau PET
17 clinical scenarios developed for which amyloid or tau PET may be considered
Binge Drinking in Retirement Tied to More Depressive Symptoms
Overall, retirement associated with higher levels of depression
Antipsychotics at Doses >75 mg a Day Linked to Risk for Tardive Dyskinesia
Significantly increased risk for tardive dyskinesia seen with doses >75 mg/day at last prescription and as maximum dose
PFAS in Drinking Water Linked to Increased Cancer Incidence
Increased cancer incidence seen in digestive, endocrine, oral cavity/pharynx, and respiratory systems between 2016 and 2021
Twenty-Nine Novel Retinal Vascular Parameters Linked to Stroke Risk
Area under receiver operating characteristic curve improved with retinal parameters, outperforming traditional risk factors
Risk for Chronic Fatigue Syndrome Higher After COVID-19
Nearly nine in 10 with chronic fatigue also meet criteria for long COVID
Most Participants With Probable Dementia Are Unaware of Diagnosis
Unawareness varies with race and is higher among Mexican Americans; unawareness not linked to caregiver burden
Vaccination Does Not Impact Long COVID Neurological Symptoms
Minor differences in neurologic symptoms seen between prevaccination infection and breakthrough infection
Hormone Therapy Not Associated With Glioma Risk in Women
Similar findings with no significant association seen when accounting for hormone therapy status and duration of use
